|
Obesity Prevention after Smoking Cessation in Menopause Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, visits or professional assistance with a real medical. We aren't doctors. Always consult your mD about Obesity Prevention after Smoking Cessation in Menopause conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Obesity Prevention after Smoking Cessation in Menopause Clinical research trials and Obesity Prevention after Smoking Cessation in Menopause health trials occur in a lot of of places throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to detect remedies for all varieties of circumstances, such as Obesity Prevention after Smoking Cessation in Menopause. Obesity Prevention after Smoking Cessation in Menopause Clinical Trials and other clinical trials allow volunteers to obtain health treatment choices before they are available to the general public. Most times the human subjects recieve professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Obesity Prevention after Smoking Cessation in Menopause clinical trial. Human subjects frequently get the finest healthcare available for their Obesity Prevention after Smoking Cessation in Menopause condition. Risks are a reality, however, and may include extra or frequent physician visits, medical dangers (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > Obesity Prevention after Smoking Cessation in Menopause  Obesity Prevention after Smoking Cessation in Menopause
Obesity Prevention after Smoking Cessation in Menopause
For Condition: Obesity,Menopause
Status: No longer recruiting
Sponsor(s): National Institute on Aging (NIA) ,
Synopsis: This study addresses the high risk of weight gain associated with smoking cessation in women. The obesity prevention pilot study is designed for the primary prevention of weight gain that can lead to overweight in normal-weight women, that can progress to obesity in women who are already overweight, and for the prevention of additional weight gain in obese women with BMI greater than or equal to 30.0. Fat and other macronutrient intake, specifically, sugar, complex carbohydrates, and protein, are analyzed as a target for individually tailored, weight control intervention following smoking cessation in Caucasian and African American women.
Details: Middle-aged women, especially African Americans, who quit smoking are at high risk for weight gain, overweight, and obesity. Postcessation weight gain has been attributed to increased food intake, which in turn, has been ascribed to a selective increase in high-sugar and other high-carbohydrate foods with a high-fat content. This study compares the relative effectiveness, for postmenopausal Caucasian and African American women, of following an empirically validated smoking cessation program with either 1) a group cessation maintenance program with standard exercise advice and food pyramid instructions for healthy eating or 2) an individually tailored, dietary-control, exercise, weight-management and cessation-maintenance program. Effectiveness is assessed by weight change from baseline to postcessation months 6, 12, and 20. The second aim is to assess overall fat and other specific macronutrient intake (sugar, complex carbohydrates, and protein) and total caloric intake with the use of a novel macronutrient self-selection paradigm in Caucasian and African-American postmenopausal women at baseline prior to smoking cessation, after being abstinent for one week, and again at 6, 12, and 20 months postcessation. The third aim is to assess whether there is differential responsiveness on the above measures in postmenopausal Caucasian vs. African-American women.
Eligibility:
Study Type: Interventional, Prevention, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 45 Years/59 Years
Genders: Female
Protocol Entry Criteria: Inclusion Criteria: - Female aged 45 - 59 at time of enrollment - African-American or Caucasian; able to confirm racial heritage of past two generations in family - Postmenopausal - Smokers (more than 10 cigarettes per day for 1 year or more) - Written physician approval to participate in program and medical clearance that use of over-the-counter nicotine replacement is not contraindicated based on patient's medical status Exclusion Criteria - Men - Age below 45 or above 59 - Nonsmokers - Currently in a standardized weight-reduction program or taking medications for weight loss - History or presence of significant psychiatric illness (e.g., eating disorders, psychosis, psychoactive substance abuse, major depression) - History of presence of severe physical illness (e.g., renal failure, hepatic failure, cancer, immunological disease) - Unable to complete long-term study commitment, including anticipating moving out of study area prior to completion of the study - Unable to confirm racial heritage of past two generations in family.
Total Enrollment: 100
Location and Contact Information:
LSU Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808
United States
Additional Information:
Study ID Numbers: AG0004;
Study Start Date: March 2000
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00064961
Other Menopause Studies:
1. Development and Evaluation of a Hormone Replacement Therapy Decision-Aid
2. Single-Dose Study of Black Cohosh and Red Clover
3. Black Cohosh Extract in Postmenopausal Breast Health
4. Buccal estrogen in toothpaste study: Systemic absorption of estradiol when administered mixed with toothpaste in postmenopausal or surgically menopausal women
5. Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
Related Studies:
Other Menopause Clinical Trials
Other Louisiana Clinical Trials
Other Baton Rouge Clinical Trials
Obesity Prevention after Smoking Cessation in Menopause
|
|
|
|
|
|
|
|
